VBI Vaccines Inc. Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
VBI Vaccines Inc. is a biotechnology company focused on immunology-driven approaches to disease prevention and treatment. It develops vaccine candidates that mimic natural virus presentation through virus-like particle platforms, including its enveloped VLP (eVLP) technology. The company targets infectious diseases such as hepatitis B, COVID-19 and related coronaviruses, cytomegalovirus, and glioblastoma. Based in Cambridge, Massachusetts, the company conducts research in Ottawa, Canada, and maintains a research and manufacturing site in Rehovot, Israel. A recent development noted in 2026 indicates VBI is pursuing In Vivo Nanoparticle technologies designed to enable antigen display that elicits durable immune responses while potentially reducing the manufacturing burden of traditional VLPs.